ACADIA Pharmaceuticals
ACAD
#3593
Rank
NZ$5.21 B
Marketcap
$31.33
Share price
0.29%
Change (1 day)
-31.55%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): NZ$0.22 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.92 Billion. In 2023 the company made an earning of -NZ$91.01 Million, an increase over its 2022 earnings that were of -NZ$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.22 B-341.89%
2023 -NZ$91.01 Million-76.09%
2022 -NZ$0.39 Billion27.41%
2021 -NZ$0.3 Billion-40.38%
2020 -NZ$0.51 Billion19.88%
2019 -NZ$0.42 Billion-3.92%
2018 -NZ$0.44 Billion-15.04%
2017 -NZ$0.52 Billion6.33%
2016 -NZ$0.49 Billion64.55%
2015 -NZ$0.3 Billion77.47%
2014 -NZ$0.17 Billion143.69%
2013 -NZ$67.67 Million81.93%
2012 -NZ$37.2 Million-8.73%
2011 -NZ$40.75 Million-251.39%
2010 NZ$26.91 M-133.2%
2009 -NZ$81.08 Million-30.82%
2008 -NZ$0.12 Billion6.43%
2007 -NZ$0.12 Billion25.89%
2006 -NZ$87.47 Million36.99%
2005 -NZ$63.85 Million37.22%
2004 -NZ$46.54 Million19.96%
2003 -NZ$38.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$66.83 Million-127.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.38 B 4,979.27%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$18.09 B 7,325.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.80 B 13,357.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$12.27 Billion-5,133.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$68.89 Million-128.26%๐Ÿ‡บ๐Ÿ‡ธ USA